Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary.

European journal of cancer (Oxford, England : 1990) - 1 Nov 2021

Pouyiourou Maria, Wohlfromm Timothy, Kraft Bianca, Hielscher Thomas, Stichel Damian, von Deimling Andreas, Delorme Stefan, Endris Volker, Neumann Olaf, Stenzinger Albrecht, Krämer Alwin, Bochtler Tilmann

Abstract excerpt

BACKGROUND: Single-site carcinoma of unknown primary (CUP) is recognised as a distinct favourable subtype in the European Society of Medical Oncology (ESMO) classification. There is broad consensus that these patients are candidates for local ablative treatment strategies with surgery and/or radiotherapy, but data on their outcomes are scarce. PATIENTS AND METHODS: In this study, we have addressed the prospects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Genes, p53

Share to Mutation

Share to Neoplasm Metastasis

Share to Neoplasms, Unknown Primary

Share to Prognosis

Source

Identifiers

PMID: 34521064
DOI: 10.1016/j.ejca.2021.08.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary.PMID 34521064Read ↗

Diagnosis and management of metastatic neoplasms with unknown primary.Semantic proximity Read ↗

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.Semantic proximity Read ↗

Does genomic profiling improve clinical outcome in carcinoma of unknown primary? - A systematic reviewSemantic proximity Read ↗

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.Semantic proximity Read ↗

Cancer of unknown primary.Semantic proximity Read ↗

Cancer of Unknown Primary Site: Missing Primary or Missing Biology?Semantic proximity Read ↗

Molecular driver alterations and their clinical relevance in cancer of unknown primary site.Semantic proximity Read ↗

Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Semantic proximity Read ↗

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.Semantic proximity Read ↗

Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling.Semantic proximity Read ↗

Genetic characterisation of molecular targets in carcinoma of unknown primary.Semantic proximity Read ↗

Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.